Finance

Lists
Why is NRXP down 4.41%?
Dive Deeper
NRXP:NASDAQ
NRX Pharmaceuticals Inc
$2.17
-4.41%
(-0.100) 1D
$2.20
+1.38% (+0.030)
After hours
Closed: Nov 2, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NRXP...
Open
$2.32
High
$2.44
Low
$2.14
Mkt. cap
93.95M
Avg. vol.
1.25M
Volume
0.00
52-wk high
$5.06
52-wk low
$1.62
EPS
-$0.74
Beta
2.08
Shares outstanding
43.30M
No. of employees
29
Open
$2.32
High
$2.44
Low
$2.14
Mkt. cap
93.95M
Avg. vol.
1.25M
Volume
0.00
52-wk high
$5.06
52-wk low
$1.62
EPS
-$0.74
Beta
2.08
Shares outstanding
43.30M
No. of employees
29
News stories
From web sources and news partners
About NRX Pharmaceuticals Inc
CEO-
Employees29
Founded2015
HeadquartersWilmington, Delaware, United States
SectorPharmaceutical industry
Websitenrxpharma.com
Analyst ratings
Based on 3 analysts giving stock ratings to NRXP in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for NRXP in the last 3 months.
Highest
Current $2.17
$50.00 (+2,204.15%)
Average
$35.00 (+1,512.90%)
Lowest
$10.00 (+360.83%)
Analyst
Recommendation
Action
Price target
Projected
Date
Thomas Shrader
BTIG
Buy
Maintained
$10.00
+360.8%
11/01/2026
Edward Woo
Ascendiant
Buy
Maintained
$50.00
+2,204.1%
09/30/2026
Patrick Trucchio
H.C. Wainwright
Buy
Reiterated
$45.00
+1,973.7%
09/21/2026
Elemer Piros
Lucid Capital
Buy
Initiated
$49.00
+2,158.1%
05/13/2026
Jason Kolbert
D. Boral Capital
Buy
Maintained
$34.00
+1,466.8%
04/20/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
242.00K
983.00K
1.07M
1.10M
Cost of goods sold
97.00K
408.00K
631.00K
675.00K
Cost of revenue
97.00K
408.00K
631.00K
675.00K
Research and development expenses
1.43M
558.00K
1.31M
2.12M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.81M
4.57M
3.81M
4.74M
Operating expense
4.26M
5.17M
5.18M
6.93M
Total operating expenses
4.36M
5.58M
5.82M
7.60M
Operating income
-4.12M
-4.59M
-4.75M
-6.50M
Other non operating income
-366.00K
1.59M
3.54M
-9.78M
EBT including unusual items
-5.89M
360.00K
-1.43M
-16.52M
EBT excluding unusual items
-4.48M
-3.67M
-1.44M
-16.52M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-5.89M
360.00K
-1.43M
-16.52M
Net profit margin
-2,433.88%
36.62%
-133.90%
-1,500.45%
Earnings per share
-0.51
0.18
-0.04
-0.24
Interest and investment income
2.00K
4.00K
5.00K
6.00K
Interest expense
-
-671.00K
-233.00K
-240.00K
Net interest expenses
2.00K
-667.00K
-228.00K
-234.00K
Depreciation and amortization charges
26.00K
42.00K
63.00K
66.00K
EBITDA
-4.11M
-4.55M
-4.68M
-6.43M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps